Antivirals with common targets against highly pathogenic viruses
- PMID: 33740455
- DOI: 10.1016/j.cell.2021.02.013
Antivirals with common targets against highly pathogenic viruses
Abstract
Historically, emerging viruses appear constantly and have cost millions of human lives. Currently, climate change and intense globalization have created favorable conditions for viral transmission. Therefore, effective antivirals, especially those targeting the conserved protein in multiple unrelated viruses, such as the compounds targeting RNA-dependent RNA polymerase, are urgently needed to combat more emerging and re-emerging viruses in the future. Here we reviewed the development of antivirals with common targets, including those against the same protein across viruses, or the same viral function, to provide clues for development of antivirals for future epidemics.
Copyright © 2021 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of Interests The authors declare that they do not have manifest conflict of interest. S.J. and L.L. have been holding research contracts with Shanxi Jinbo Bio-Pharmaceutical Inc Co. and hold patents covering the peptide-based pan-CoV fusion inhibitors. H.Y. holds patents covering the CoV Mpro inhibitors.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
